ATA Inc (ATAI)
Loading...
Symbols:
ATAI Forum Topics
loading ...Recent ATAI Articles
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
China ADRs: Mixed July [view article]
I should have mentioned JASO which also reports this week. It was recently given a new buy recommendation. Also SOL has steadily moved up from a 2 star CAPS rating to a 5 star CAPS rating. It should do well. ReplyChina ADRs: Mixed July [view article]
Both LDK and CSIQ report earnings this week (8/11/08-8/15/08). Other solar stocks report the next week such as SOL, STP, and TSL (perhaps others also). After the big down movement recently, I think we can expect an up movement over the next couple of weeks from these stocks. Virtually all should report great earnings. Hopefully LDK will report some positive guidance about their polysilicone plant also. The ones will great multiples seem likely to move up substanitally. This would include LDK, SOL, CSIQ, and TSL. LDK's movement will likely be dependent on its margins and its guidance about the two polysilicone plants it is building. The others should all move up on great results. The highest rated ones should move up more easily. The average analyst ratings for the latter three stocks are: SOL (1.8), CSIQ (2.0), and TSL (2.3). The FPE's are: SOL (6.88), CSIQ (7.40), and TSL (6.23). It looks like there is likely some room for these stocks to move up. They all have low PEG ratios, especially when compared to FSLR (which has moved down after its great earnings). FSLR's PEG ratio is currently 1.29. FSLR's FPE is 37.54 (even after the great earnings). The PEG ratios of the others are: LDK (.34), SOL (.26), CSIQ (.39), and TSL(.28). I think you can see where these other solar stocks may behave differently than FSLR at this point in time. Of course, there is still the possible headwind of oil prices continuing to go down. Replyres
China ADRs: Mixed July [view article]
what a joke..China aluminum at 21 bucks...YGE at 16..who would have thunk it ReplyChina ADRs: Severe Loss in June [view article]
Thanks for the good Richard.
[URL="healthproductsreview.n...;]health products[/URL]
Reply
China ADRs: Severe Loss in June [view article]
buy stock at $6hold stock until MPEL City of Dreams opens in mid 2009
Reply
IPO Watch: Battered, Beaten and Pulped in 2008 (Except Visa) [view article]
Didn't VWINNER say that Visa would NEVER NEVER NEVER go under $75.00 in our lifetime!! He knows nothing!! VWINNER should use his time to take care of his own blog and his little band of followers: "Rah, Rah, Go Visa Go!!" VWINNER go back to your own blog where they idle and worship you. ReplyIPO Watch: Battered, Beaten and Pulped in 2008 (Except Visa) [view article]
VWINNER do us all a favor and don't provide us with you valuable insightwhat's that? last chance to buy V in the 70's a month ago? How about in the 60's this month. and now we have RONJSQ with his expert advice and it's free. Reply
IPO Watch: Battered, Beaten and Pulped in 2008 (Except Visa) [view article]
After a break from the site I'll be providing valuable insight and commentary.I couldn't stay away for long.
I missed you guys.
Jon Reply
IPO Watch: Battered, Beaten and Pulped in 2008 (Except Visa) [view article]
I m Financial Analyst at Major Wall St Firm. Usually i dont provide free services, but due to current sentiment of the market, i think it as a moral responsibility to help you all out. Buy VISA(V). Also Buy Energy Stocks like Chesapeake Energy(CHK). This will be a good hedge. Buy Natural Gas stocks like SouthWestern Energy(SWN). A great stock to make good huge profit is Sirius Satellite Radio(SIRI). Fcc is soon likely to approve its merger with XM.Sirius is extremely undervalued stock right now. As soon as the merger is approved, it will skyrocket to $10 a stock . Healthcare is doing great and will soar,so buy Merck(MRK), Pfizer(PFE) etc. Microsoft(MSFT) is a great buy at this price as well.Buy these stocks on Monday or Tuesday - VISA(V), Sirius(SIRI), Chesapeake Energy(CHK), Southwestern Energy(SWN), Merck(MRK), Pfizer(PFE), Microsoft(MSFT).Reply
IPO Watch: Battered, Beaten and Pulped in 2008 (Except Visa) [view article]
The writing is on the wall for Visa. This is a great long term holding. It will be even better when Joe Investor figures out it's not tied into the financial sector. ReplyIPO Watch: Battered, Beaten and Pulped in 2008 (Except Visa) [view article]
Yes, man, I also get more V at 78 yesterday. Replyres
IPO Watch: Battered, Beaten and Pulped in 2008 (Except Visa) [view article]
Visa is getting pummeled today and I am, Buying like it is a year end sale. Got some at 74.50 and waiting with a loaded trigger for even better pricing. EOY 2009 I look like a genius Replyres
China ADRs: Severe Loss in June [view article]
YGE is the best Value if you Look at current P/E forward P/E and PEG...check it out and tell me I am wrong ReplyIPO Watch: Battered, Beaten and Pulped in 2008 (Except Visa) [view article]
How about Intrepid Potash (IPI), a big winner?Some financial IPOs were disasters: AGNC, FSC. FSC came at $15 and is now under $10, all in the last 30 days. Reply
China ADRs: Severe Loss in June [view article]
Thanks to stockaccumulator for his excellent analysis of Renesolar. Similar may be said about Wuxi Pharmatech. WX is already one of the largest research partners for the global pharmaceutical industry and analyst do not seem to understand this company. The rational for pouring business into Wuxi is simple: Why would you want to spend 80-100k per year for a scientist in the US if you can have the same job done for less than half at Wuxi? Such FTE costs are not tenable in the long-term for US companies, and with the risk involved in drug development FTE's are even more costly if you rapidly have to cut jobs due to restructuring if projects fail. The brains need to be here, the hands can be at Wuxi. Working in the pharmaceutical industry myself I know that their reputation is excellent, and so is their service. Many of their scientists have been trained in the United States and quality of work is 100% of what is being achieved in this country. With Big-Pharma moving research activities to Asia (GSK for example operates centers of excellence in Singapore and Shanghai) and job-cuts in the US and Europe this company is only going to expand more rapidly. And be sure - this is NOT a biotech. Their operations are comparatively low risk with high growth. It is contract research and development. Service for fee. There is an additional advantage: Wuxi can help achieve compliance with regulatory requirements in China. The latter will be key to development of this vast market for current and new medicines. In my humble opinion, WX trading below their IPO price is a joke. Reply